Department of Forensic Medicine & Toxicology, Faculty of Veterinary Medicine, University of Sadat City, Sadat City, Egypt.
Department of Biochemistry and Chemistry of Nutrition, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Environ Toxicol. 2022 Aug;37(8):1914-1924. doi: 10.1002/tox.23537. Epub 2022 Apr 11.
Aluminum oxide nanoparticles (Al O -NPs) are exceedingly used in various industrial and commercial applications, providing growing concerns about their potential adverse impacts on animals and human health. Therefore, the present study was conducted to evaluate the potential protective effect of sesamol (SML) against the induced hepatorenal toxicity of Al O -NPs. Forty male rats were randomly assigned into four groups and treated orally for 28 consecutive days. Control group received distilled water. SML group received SML (100 mg/kg bw). Al O -NPs group received Al O -NPs (100 mg/kg bw). SML + Al O -NPs group received SML 2 h prior to Al O -NPs. The results revealed that Al O -NPs significantly increased serum alanine aminotransferase and aspartate aminotransferase activities and serum urea and creatinine levels. Moreover, Al O -NPs induced a significant elevation in malondialdehyde level with significant reduction in reduced glutathione content and catalase and superoxide dismutase activities, together with a marked increase of 8-hydroxy-2-desoxyguanosine level in the hepatic and renal tissues. Also, up-regulations of glutathione-S-transferase, tumor necrosis factor-alpha, and caspase-3 mRNA gene expressions were recorded in the liver and kidneys. Additionally, Al O -NPs induced multifocal areas of necrosis in hepatic parenchyma with glomerular mesangial cell proliferation and glomerular sclerosis in kidney tissues. Conversely, concomitant treatment with sesamol mitigated Al O -induced hepatorenal toxicity evidenced by improvement of liver and kidney functions that correlated with regulation of oxidant/antioxidant status, inflammatory, and apoptotic biomarkers and reduction of DNA and tissues damages. In conclusion, sesamol could exert a promising protective role against hepatorenal toxicity of Al O -NPs, possibly via its antioxidant, anti-inflammatory and anti-apoptotic properties.
氧化铝纳米粒子(Al O -NPs)在各种工业和商业应用中被广泛使用,这引发了人们对其潜在的动物和人类健康不良影响的关注。因此,本研究旨在评估芝麻酚(SML)对 Al O -NPs 诱导的肝肾功能毒性的潜在保护作用。将 40 只雄性大鼠随机分为 4 组,连续 28 天口服给药。对照组给予蒸馏水。SML 组给予 SML(100mg/kg bw)。Al O -NPs 组给予 Al O -NPs(100mg/kg bw)。SML+Al O -NPs 组在给予 Al O -NPs 前 2 小时给予 SML。结果表明,Al O -NPs 显著增加了血清丙氨酸氨基转移酶和天冬氨酸氨基转移酶活性以及血清尿素和肌酐水平。此外,Al O -NPs 诱导了丙二醛水平的显著升高,同时还原型谷胱甘肽含量、过氧化氢酶和超氧化物歧化酶活性显著降低,肝和肾组织中 8-羟基-2-脱氧鸟苷水平显著升高。此外,还记录到肝和肾组织中谷胱甘肽-S-转移酶、肿瘤坏死因子-α和半胱氨酸天冬氨酸蛋白酶-3 mRNA 基因表达上调。此外,Al O -NPs 诱导肝实质多灶性坏死,肾小球系膜细胞增殖和肾组织肾小球硬化。相反,芝麻酚的伴随治疗减轻了 Al O -NPs 诱导的肝肾功能毒性,这与改善肝功能和肾功能有关,与氧化应激/抗氧化状态、炎症和细胞凋亡生物标志物的调节以及 DNA 和组织损伤的减少相关。总之,芝麻酚可能通过其抗氧化、抗炎和抗凋亡特性对 Al O -NPs 诱导的肝肾功能毒性发挥有希望的保护作用。